Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis

Pancreatology

Volumn 9, Issue 5, 2009, Pages 694-699

  Matsubayashi, Hiroyuki ^a   Furukawa, Hiroyoshi ^a   Maeda, Atsuyuki ^a   Matsunaga, Kazuya ^a   Kanemoto, Hideyuki ^a   Uesaka, Katsuhiko ^a   Fukutomi, Akira ^a   Ono, Hiroyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Autoimmune pancreatitis, diagnosis; Autoimmune pancreatitis, systemic lesions; Positron emission tomography; Steroid therapy

Indexed keywords

AUTOANTIBODY; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PREDNISOLONE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; AORTA WALL; ARTICLE; AUTOIMMUNE PANCREATITIS; BIOACCUMULATION; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DRUG ACCUMULATION; EQUIPMENT; EVALUATION; FEMALE; HEPATOBILIARY SYSTEM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LESIONS AND DEFECTS; LYMPH NODE; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE; SALIVARY GLAND; STEROID THERAPY; SYSTEMIC DISEASE;

EID: 68549128777     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000199439     Document Type: Article

References (44)

1. Furukawa H, Ikuma H, Seki A, Yokoe K, Yuen S, Aramaki T, Yamagushi S: Positron emission tomography scanning is not superior to whole-body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut 2006; 55: 1007-1011.
2. Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, Klever P, Sabri O, Schumpelick V, Buell U: Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med 1997; 24: 678-682.
3. Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ: PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 2004; 24: 1411-1431.
4. Shreve PD, Anzai Y, Wahl RL: Pitfalls in oncologic diagnosis with FDG-PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77, 150-151.
5. Schoder H, Gonen M: Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med 2007; 48(suppl 1):4S-18S.
6. Zhuang H, Alavi A: 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002; 32: 47-59.
7. Inokuma T, Tamaki N, Torizuka T, Magata Y, Fujii M, Yonekura Y, Kajiyama T, Ohshio G, Imamura M, Konishi J: Evaluation of pancreatic tumors with positron emission tomography and 18 F-fluorodeoxyglucose: comparison with CT and US. Radiology 1995; 195: 345-352.
8. Kalady MF, Clary BM, Clark LA, Gottfried M, Rohren EM, Coleman RE, Pappas TN, Tyler DS: Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol 2002; 9: 799-806.
9. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremerius U, Schumpelick V, Mittermayer C, Bull U: 18 F-fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192: 79-86.
10. Kobayashi Y, Ishii K, Oda K, Nariai T, Tanaka Y, Ishiwata K, Numano F: Aortic wall inflammation due to Takayasu arteritis imaged with 18 F-FDG PET co-registered with enhanced CT. J Nucl Med 2005; 46: 917-922.
11. Beckers C, Jeukens X, Ribbens C, Andre B, Marcelis S, Leclercq P, Kaiser MJ, Foidart J, Hustinx R, Malaise MG: 18 F-FDG-PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 2006; 33: 275-280.
12. Wu YW, Kao HL, Chen MF, Lee BC, Tseng WY, Jeng JS, Tzen KY, Yen RF, Huang PJ, Yang WS: Characterization of plaques using F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 2007; 48: 227-233.
13. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N: Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98: 2694-2699.
14. Okazaki K, Uchida K, Matsushita M, Takaoka M: How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007; 42(suppl 18):32-38.
15. Ohara H, Nakazawa T, Sano H, Ando T, Okamoto T, Takada H, Hayashi K, Kitajima Y, Nakao H, Joh T: Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005; 31: 232-237.
16. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A: Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol 2005; 39: 904-907.
17. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S: Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-1205.
18. Matsubayashi H, Furukawa H, Uesaka K, Sasaki K, Ono H, Hruban RH: Autoimmune pancreatitis accompanied with cholecystitis, periaortitis and pseudotumors of the liver. Case Rep Gastroenterol 2008; 2: 155-161.
19. Ito T, Nishimori I, Inoue N, Kawabe K, Gibo J, Arita Y, Okazaki K, Takayanagi R, Otsuki M: Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007; 42(suppl 18):50-58. (Pubitemid 46863938)
20. Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, Arakura N, Imai Y, Hasebe O, Kawa S: Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004; 99: 932-937.
21. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Sawabu N: Longterm prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas 2005; 30: 31-39.
22. Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A: Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005; 5: 234-240.
23. Muraki T, Hamano H, Ochi Y, Komatsu K, Komiyama Y, Arakura N, Yoshizawa K, Ota M, Kawa S, Kiyosawa K: Autoimmune pancreatitis and complement activation system. Pancreas 2006; 32: 16-21.
24. Kubota K, Iida H, Fujisawa T, Yoneda M, Inamori M, Abe Y, Kirikoshi H, Saito S, Ohshiro H, Kakuta Y, Nakajima A: Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007; 66: 1142-1151.
25. Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD: Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999; 40: 1784-1791.
26. Komatsu K, Hamano H, Ochi Y, Takayama M, Muraki T, Yoshizawa K, Sakurai A, Ota M, Kawa S: High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 2005; 50: 1052-1057.
27. Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, Nakai Y, Sasahira N, Tsujino T, Yoshida H, Kawabe T, Omata M: Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007; 56: 1719-1724.
28. Uehara T, Hamano H, Kawakami M, Koyama M, Kawa S, Sano K, Honda T, Oki K, Ota H: Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 2008; 58: 118-125.
29. Hyodo N, Hyodo T: Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol 2003; 38: 1155-1161.
30. Nakazawa T, Ohara H, Sano H, Ando T, Imai H, Takada H, Hayashi K, Kitajima Y, Joh T: Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc 2007; 65: 99-108.
31. Manfredi R, Graziani R, Cicero C, Frulloni L, Carbognin G, Mantovani W, Mucelli RP: Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 2008; 247: 435-443.
32. Procacci C, Carbognin G, Biasiutti C, Frulloni L, Bicego E, Spoto E, el-Khaldi M, Bassi C, Pagnotta N, Talamini G, Cavallini G: Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology 2001; 1: 246-253.
33. Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, Jimi M, Sumii T, Masuda K: Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998; 170: 1323-1327.
34. Farrell JJ, Garber J, Sahani D, Brugge WR: EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004; 60: 927-936.
35. Maschauer S, Prante O, Hoffmann M, Deichen JT, Kuwert T: Characterization of 18 FFDG uptake in human endothelial cells in vitro. J Nucl Med 2004; 45: 455-460.
36. Forstrom LA, Mullan BP, Hung JC, Lowe VJ, Thorson LM: 18 F-FDG labelling of human leukocytes. Nucl Med Commun 2000; 21: 691-694.
37. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T: Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
38. Paik JY, Lee KH, Ko BH, Choe YS, Choi Y, Kim BT: Nitric oxide stimulates 18 F-FDG uptake in human endothelial cells through increased hexokinase activity and GLUT-1 expression. J Nucl Med 2005; 46: 365-370.
39. Reske SN, Grillenberger KG, Glatting G, Port M, Hildebrandt M, Gansauge F, Beger HG: Overexpression of glucose transporter- 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med 1997; 38: 1344-1348.
40. Burgman P, Odonoghue JA, Humm JL, Ling CC: Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med 2001; 42: 170-175.
41. Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, Imamura M, Sakahara H, Konishi J: FDG-PET of autoimmune- related pancreatitis: preliminary results. Eur J Nucl Med 2000; 27: 1835-1838.
42. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M: The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging 2007; 34: 2088-2095. (Pubitemid 350212140)
43. Yasuda S, Shohtsu A, Ide M, Takagi S, Kijima H, Horiuchi M: Elevated 18 F-FDG uptake in plasmacyte-rich chronic maxillary sinusitis. Clin Nucl Med 1998; 23: 176-178.
44. Kanno A, Satoh K, Kimura K, Masamune A, Asakura T, Unno M, Matsuno S, Moriya T, Shimosegawa T: Autoimmune pancreatitis with hepatic inflammatory pseudotumor. Pancreas 2005; 31: 420-423.